Accredited (Credits: 1.5)
Free
1h 41min
Audio: English
Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.
4.4
This activity is supported by an independent support grant from MSD
This course is accredited with 1.5 ECMEC credits valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.
See more information on the accreditation at: Accreditation
1h 41min
Obstetrics, Gynecology, General practice, Family medicine, Oncology, Gynecologic oncology, General surgical oncology
Prof. Isabelle Ray-Coquard is a prominent oncologist based at the Centre Léon Bérard in Lyon, France, where she specializes in rare gynaecological cancers and sarcomas. She obtained her medical degree in 1997 and has since developed a significant focus on translational research, particularly in ovarian cancer, coordinating the national reference center for rare ovarian cancers. Prof. Ray-Coquard has held various leadership roles in cancer research organizations, including serving as the clinical chair of the ENGOT network and Past President of the GINECO group, which is dedicated to gynaecological cancer research. She is also involved in multidisciplinary consultation meetings for sarcomas and gastrointestinal stromal tumors (GISTs). Her contributions to the field are recognized through her extensive publications and active participation in international oncology societies, emphasizing her commitment to improving treatment outcomes for patients with rare cancers.
Prof. Dr. Isabelle Ray-Coquard received honoraria (self) from: Agenus, Blueprint, BMS, PharmaMar, Genmab, Pfizer, AstraZeneca, Roche, GSK, MSD, Deciphera, Mersena, Merck Sereno, Novartis, Amgen, Macrogenics, Tesaro and Clovis; Honoraria (institution) from GSK, MSD, Roche and BMS; Advisory/consulting fees from Abbvie, Agenus, Advaxis, BMS, ESAÏ, Daichi, PharmaMar, Genmab, Pfizer, AstraZeneca, Roche/Genentech, GSK, MSD, Deciphera, Mersana, Merck Sereno, Novartis, Amgen, Tesaro and Clovis; research grant/funding (self) from MSD, Roche and BMS; Research grant/funding (institution) from MSD, Roche, BMS, Novartis, Astra Zeneca and Merck Sereno; Travel support from Roche, MSD, AstraZeneca and GSK.
“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.” — Omar I.
Spain
“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.” — Wil A.
Netherlands
“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.” — Carmen S.
Spain